نتایج جستجو برای: معیار ada

تعداد نتایج: 48257  

Journal: :The Journal of biological chemistry 1988
K Takahashi Y Kawazoe K Sakumi Y Nakabeppu M Sekiguchi

The adaptive response is a cellular process to induce DNA repair enzymes in response to a challenge of alkylating agents. In this process Ada protein, the product of the ada gene, plays a major role; it accepts the methyl groups of the methylated DNA at the cysteine residues of its own molecule, and the methylated form of Ada protein promotes transcription of its own gene, thereby triggering in...

1998
David E. Emery Robert F. Mathias Karl A. Nyberg

This paper describes an automated approach for generating Ada bindings from Java class files. We start with the set of Java features that require a visible Ada binding, and an Ada compiler’s definition of how to interface Ada and Java. We discuss how to obtain the Java definitions from the class file and then translate them into an Ada binding (using the GNAT binding approach). While it is poss...

2013
Chamaida Plasencia Dora Pascual-Salcedo Sara García-Carazo Leticia Lojo Laura Nuño Alejandro Villalba Diana Peiteado Florencia Arribas Jesus Díez Maria Teresa López-Casla Emilio Martín-Mola Alejandro Balsa

INTRODUCTION Anti-TNF drugs have proven to be effective against spondyloarthritis (SpA), although 30% of patients fail to respond or experience adverse events leading to treatment discontinuation. In rheumatoid arthritis, the presence of anti-drug antibodies (ADA) against the first TNF inhibitor influences the outcome after switching. Our aim was to assess whether the response to a second anti-...

2017
Aisha V. Sauer Raisa Jofra Hernandez Francesca Fumagalli Veronica Bianchi Pietro L. Poliani Chiara Dallatomasina Elisa Riboni Letterio S. Politi Antonella Tabucchi Filippo Carlucci Miriam Casiraghi Nicola Carriglio Manuela Cominelli Carlo Alberto Forcellini Federica Barzaghi Francesca Ferrua Fabio Minicucci Stefania Medaglini Letizia Leocani Giancarlo la Marca Lucia D. Notarangelo Chiara Azzari Giancarlo Comi Cristina Baldoli Sabrina Canale Maria Sessa Patrizia D’Adamo Alessandro Aiuti

Adenosine Deaminase (ADA) deficiency is an autosomal recessive variant of severe combined immunodeficiency (SCID) caused by systemic accumulation of ADA substrates. Neurological and behavioral abnormalities observed in ADA-SCID patients surviving after stem cell transplantation or gene therapy represent an unresolved enigma in the field. We found significant neurological and cognitive alteratio...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1987
A L Akeson D A Wiginton J C States C M Perme M R Dusing J J Hutton

Adenosine deaminase (ADA; adenosine aminohydrolase, EC 3.5.4.4) deficiency is one cause of the genetic disease severe combined immunodeficiency. To identify mutations responsible for ADA deficiency, we synthesized cDNAs to ADA mRNAs from two cell lines, GM2756 and GM2825A, derived from ADA-deficient immunodeficient patients. Sequence analysis of GM2756 cDNA clones revealed a different point mut...

2016
Tsutomu Mizoshita Satoshi Tanida Keiji Ozeki Takahito Katano Takaya Shimura Yoshinori Mori Eiji Kubota Hiromi Kataoka Takeshi Kamiya Takashi Joh

There is little evidence regarding the maintenance of long-term clinical remission by adalimumab (ADA) therapy in Crohn's disease (CD) patients naïve to anti-tumor necrosis factor treatment (naïve CD patients), since most CD patients are treated with ADA after infliximab (IFX) therapy. The long-term clinical response to ADA was retrospectively analyzed in 17 naïve CD patients for at least 24 mo...

Journal: :The Journal of clinical investigation 2001
S G Apasov M R Blackburn R E Kellems P T Smith M V Sitkovsky

Adenosine deaminase (ADA) deficiency in humans results in a severe combined immunodeficiency (SCID). This immunodeficiency is associated with severe disturbances in purine metabolism that are thought to mediate lymphotoxicity. The recent generation of ADA-deficient (ADA(-/-)) mice has enabled the in vivo examination of mechanisms that may underlie the SCID resulting from ADA deficiency. We demo...

2017
Jenny Link Ryan Ramanujam Michael Auer Malin Ryner Signe Hässler Delphine Bachelet Cyprien Mbogning Clemens Warnke Dorothea Buck Poul Erik Hyldgaard Jensen Claudia Sievers Kathleen Ingenhoven Nicolas Fissolo Raija Lindberg Verena Grummel Naoimh Donnellan Manuel Comabella Xavier Montalban Bernd Kieseier Per Soelberg Sørensen Hans-Peter Hartung Tobias Derfuss Andy Lawton Dan Sikkema Marc Pallardy Bernhard Hemmer Florian Deisenhammer Philippe Broët Pierre Dönnes Julie Davidson Anna Fogdell-Hahn

Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a well-integrated part of the clinical care of multiple sclerosis (MS) in several European countries. ADA data generated in Europe during the more than 10 years of ADA monitoring in MS patients treated with interferon beta (IFNβ) and natalizumab have been pooled and characterized through collaboration within a European ...

Journal: :Nucleic acids research 1987
T M Berkvens E J Gerritsen M Oldenburg C Breukel J T Wijnen H van Ormondt J M Vossen A J van der Eb P Meera Khan

We have investigated the structural gene for adenosine deaminase (ADA) in a female infant with ADA deficiency associated severe combined immune deficiency (ADA-SCID) disease and her family by DNA restriction-fragment-length analysis. In this family a new ADA-specific restriction-fragment-length variant was detected, which involves a 3.2-kb deletion spanning the ADA promoter as well as the first...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید